Form 4 for CLB Core Laboratories Inc. /DE/
Accepted 2025-04-02 00:00:00 ET · period of report 2025-04-01 · accession 0000950170-25-049166 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-02 | 2025-04-01 | CLB | Carnes Martha Z. | Dir | M - OptEx | $0.00 | +9,317 | 46.3K | +25% | $0 |
| D | 2025-04-02 | 2025-04-01 | CLB | Carnes Martha Z. | Dir | A - Grant | $0.00 | +8,069 | 8,069 | New | $0 |
| D | 2025-04-02 | 2025-04-01 | CLB | Carnes Martha Z. | Dir | M - OptEx | $0.00 | -9,317 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-01 | M | A | 9,317 | $0.00 | 46,328 | D | — | — | |
| 2 | Derivative | Restricted Shares | 2025-04-01 | A | A | 8,069 | $0.00 | 8,069 | D | $0.00 · — to — | 8,069 Common Stock | (F1) The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2026, subject to the terms of issuance. |
| 3 | Derivative | Restricted Shares | 2025-04-01 | M | D | 9,317 | $0.00 | 0 | D | $0.00 · — to — | 9,317 Common Stock | (F2) The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2025. |